.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Cardiovascular disease (CVD) remains a primary global health concern, with elevated LDL-cholesterol serving as a critical risk factor. While marine fish consumption is traditionally linked to better heart health, standard omega-3 fatty acids like EPA and DHA often fail to significantly lower cholesterol levels. However, recent research into cetoleic acid LDL reduction suggests that other components of fish oil might offer potent lipid-lowering benefits. Cetoleic acid (CA), a long-chain monounsaturated fatty acid found in species like herring, is now emerging as a promising candidate for metabolic health intervention.
A recent randomised, double-blind controlled clinical trial investigated the impact of CA on 80 adults with overweight or obesity. Researchers divided participants into two specific groups for an eight-week intervention. The first group received a cetoleic acid concentrate (CECO), providing 1480 mg of CA daily. In contrast, the comparator group (SOYO3) received soybean oil mixed with a standard omega-3 concentrate. Consequently, this design allowed investigators to isolate the effects of CA from traditional polyunsaturated fatty acids.
The study findings revealed a meaningful shift in lipid profiles. Specifically, the group receiving the cetoleic acid concentrate saw a statistically significant reduction in LDL-cholesterol compared to the control group. Data analysis showed a relative reduction of approximately 7% in the CECO group (P=0.033). Furthermore, the researchers utilized ANCOVA with body fat percentage as a covariate to ensure the results were specifically due to the fatty acid intake rather than weight fluctuations. Therefore, these results suggest that cetoleic acid LDL reduction is a distinct physiological effect of this omega-11 fatty acid.
Earlier rodent studies hinted at this potential, showing lower LDL concentrations after CA intake. Unlike EPA and DHA, which primarily target triglycerides, CA appears to influence cholesterol metabolism directly. Additionally, some evidence suggests CA might enhance the body's internal conversion of alpha-linolenic acid into EPA/DHA, though the cholesterol-lowering effect seems independent of this pathway. For clinicians in India, where dyslipidemia is prevalent among overweight populations, this fatty acid represents a potential new tool in the nutraceutical arsenal for cardiovascular risk management.
Cetoleic acid, also known as omega-11, is a long-chain monounsaturated fatty acid found in high concentrations in North Atlantic pelagic fish like herring and mackerel.
Most fish oils focus on EPA and DHA, which are effective at lowering triglycerides but have a negligible effect on LDL-cholesterol. Cetoleic acid specifically demonstrates an ability to reduce LDL levels.
No, cetoleic acid is currently viewed as a dietary supplement or functional food ingredient. It should be used as part of a comprehensive lifestyle or therapeutic plan under medical supervision.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice. Always seek the advice of a qualified healthcare provider regarding any medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Hansen K et al. Supplementation with a cetoleic acid concentrate decreased the serum LDL-cholesterol concentration in healthy adults with overweight or obesity. A randomised double-blind controlled clinical trial. Br J Nutr. 2026 May 06. doi: 10.1017/S0007114526107375. PMID: 42087284.
Nundal C, et al. Fish oils rich in omega-11 (cetoleic acid) may significantly reduce cholesterol and triglyceride levels. Frontiers in Nutrition. 2024.
Wakeman M, et al. CETO3 omega-11 raises omega-3 index more efficiently than standard fish oil. University of Sunderland Research Repository. 2024.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Recent trial data shows 8 weeks of cetoleic acid supplementation reduces LDL-cholesterol by 7% in overweight adults, offering a new tool for lipid managemen...
4 months ago
A large NHANES cohort study reveals that higher Healthy Eating Index scores significantly reduce all-cause mortality risk in CKD patients by 45%. This analysis highlights the importance of comprehensive diet quality and medical nutrition therapy in renal care to optimize long-term clinical survival.
Today
Explore real-world data showing how private oncogenetics and molecular tumor boards achieve 3-week consult turnaround, high ctDNA actionability, and vital germline variant detection, enhancing individualized cancer care and familial risk assessment.
Today
A meta-analysis of 13 propensity score-matched studies shows ViV-TAVR delivers lower early mortality and reduced bleeding compared to redo-SAVR for degenerated bioprosthetic aortic valves, though long-term hemodynamics warrant careful anatomical and patient-centered evaluation.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Today
The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today
